Woods Scott E, Noble Greg, Smith J Michael, Hasselfeld Kim
Bethesda Family Medicine Residency Program, Good Samaritan Hospital Surgical Residency Program, Cincinatti, OH 45212, USA.
J Am Coll Surg. 2003 Mar;196(3):428-34. doi: 10.1016/S1072-7515(02)01756-8.
We prospectively assess if there are any outcome differences between men and women undergoing coronary artery bypass graft surgery.
This is an eight-year, prospective, hospitalization cohort study. Data were collected on 225 variables concurrently with admission. The main outcome was mortality. In addition, we evaluated 12 morbidity outcomes. To minimize confounding, we controlled for 18 other variables.
We analyzed 5,324 patients (1,742 women; 3,582 men). Women were significantly older, with more African Americans and more Medicaid-insured (p < 0.05). Men had significantly higher body surface area, creatinine, tobacco history, prior myocardial infarctions, left ventricular hypertrophy, and cardiac pump time (p < 0.05). Women had significantly more diabetes, hypercholesterolemia, hypertension, previous cerebrovascular disease, urgency of the surgical procedure, fewer arterial grafts, and reduced functional capacity by the New York Heart Association classification (p < 0.05). Using multiple regression analysis there was no difference for mortality, positive bacterial cultures, ICU length of stay, arrhythmias, reoperation for bleeding, pulmonary complications, gastrointestinal complications, and return to the ICU. Women had significantly more intraoperative complications (RR = 2.09, 95% CI 1.35-3.23), length of stay (RR = 1.01, 95% CI 1.002-1.027), and low cardiac output conditions (RR = 1.10, 95% CI 1.01-1.20). Males developed more neurologic complications (RR = 0.85, 95% CI 0.75-0.95).
Women undergoing coronary artery bypass graft surgery have more comorbidities at surgical presentation compared with men. Women have more unadjusted mortality, which is confounded by the difference in age and body surface area. But, even after multiple adjustments, female gender is a predictor of higher morbidity in patients undergoing coronary artery bypass graft.
我们前瞻性评估接受冠状动脉搭桥手术的男性和女性在预后方面是否存在差异。
这是一项为期八年的前瞻性住院队列研究。在入院时同时收集了225个变量的数据。主要结局是死亡率。此外,我们评估了12种发病结局。为尽量减少混杂因素,我们对其他18个变量进行了控制。
我们分析了5324例患者(1742例女性;3582例男性)。女性年龄显著更大,非裔美国人更多,医疗补助保险覆盖者更多(p<0.05)。男性的体表面积、肌酐、吸烟史、既往心肌梗死、左心室肥厚和心脏泵血时间显著更高(p<0.05)。女性糖尿病、高胆固醇血症、高血压、既往脑血管疾病、手术紧迫性、动脉移植物较少以及根据纽约心脏协会分级功能能力降低的情况显著更多(p<0.05)。使用多元回归分析,在死亡率、阳性细菌培养、重症监护病房住院时间、心律失常、因出血再次手术、肺部并发症、胃肠道并发症以及返回重症监护病房方面没有差异。女性术中并发症显著更多(相对危险度=2.09,95%置信区间1.35 - 3.23)、住院时间(相对危险度=1.01,95%置信区间1.002 - 1.027)以及低心排血量情况(相对危险度=1.10,95%置信区间1.01 - 1.20)。男性发生更多神经系统并发症(相对危险度=0.85,95%置信区间0.75 - 0.95)。
与男性相比,接受冠状动脉搭桥手术的女性在手术时合并症更多。女性未经调整的死亡率更高,这受到年龄和体表面积差异的混杂影响。但是,即使经过多次调整,女性性别仍是冠状动脉搭桥手术患者发病率较高的一个预测因素。